Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Richter

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcomeRainer Hamacher, Xiaofei Liu, Markus K Schuler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup StudyViktor Grünwald, Annika Karch, Markus Schuler, et al.
European Journal of Cancer Care|August 3, 2021
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa)Martin Eichler, Daniel Pink, Franka Menge, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 16, 2024
[ePROs in the routine care of a major oncology center: Results and experiences]Martin Eichler, Leopold Hentschel, Beate Hornemann, et al.
British Journal of Cancer|January 21, 2022
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa)Martin Eichler, Susanne Singer, Leopold Hentschel, et al.
Frontiers in Endocrinology|September 15, 2023
Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa studyMartin Eichler, Leopold Hentschel, Susanne Singer, et al.
Cancers|December 3, 2020
The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany-Cross-Sectional Results of a Nationwide Observational Study (PROSa)Martin Eichler, Leopold Hentschel, Stephan Richter, et al.
Oncology Research and Treatment|April 22, 2021
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa StudyMartin Eichler, Dimosthenis Andreou, Henriette Golcher, et al.
Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcomaChristoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcomeRainer Hamacher, Xiaofei Liu, Markus K Schuler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup StudyViktor Grünwald, Annika Karch, Markus Schuler, et al.
European Journal of Cancer Care|August 3, 2021
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa)Martin Eichler, Daniel Pink, Franka Menge, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 16, 2024
[ePROs in the routine care of a major oncology center: Results and experiences]Martin Eichler, Leopold Hentschel, Beate Hornemann, et al.
British Journal of Cancer|January 21, 2022
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa)Martin Eichler, Susanne Singer, Leopold Hentschel, et al.
Frontiers in Endocrinology|September 15, 2023
Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa studyMartin Eichler, Leopold Hentschel, Susanne Singer, et al.
Cancers|December 3, 2020
The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany-Cross-Sectional Results of a Nationwide Observational Study (PROSa)Martin Eichler, Leopold Hentschel, Stephan Richter, et al.
Oncology Research and Treatment|April 22, 2021
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa StudyMartin Eichler, Dimosthenis Andreou, Henriette Golcher, et al.
Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcomaChristoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Pageof 7